• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

best adhd medication for adults Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. Little data exists about how long-term exposure to these medications could affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental disorders such as hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should consider the benefits of taking it against the possible dangers for the fetus. Physicians do not have the necessary data to give clear guidelines however they can provide information on benefits and risks that can help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy were not at greater risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants during early pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure correct case classification and to limit the chance of bias.

The study conducted by the researchers was not without its limitations. Most important, they were unable to separate the effects of the medication from the effects of the underlying disorder. This limitation makes it difficult to know whether the limited associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. Additionally the researchers did not examine long-term offspring outcomes.

The study revealed that infants whose mother took adhd medication list uk medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications used to treat adhd during early pregnancy may be offset by the greater benefit to both the mother and child from continued treatment for the woman's disorder. Physicians should discuss this with their patients and, where possible, assist them in developing strategies for improving their coping skills that can lessen the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether to keep or end treatment during pregnancy is a question that more and more physicians confront. These decisions are frequently taken without clear and authoritative evidence. Instead, doctors must consider their own expertise, the experience of other doctors and the research on the topic.

Particularly, the subject of possible risks to the baby can be tricky. Many of the studies on this topic are based on observational evidence instead of controlled research and their conclusions are often contradictory. The majority of studies restrict their analysis to live births, which may underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both the data from deceased and live births.

Conclusion Some studies have shown a positive correlation between adhd medications for adults medications and certain birth defects, other studies have not shown such a relationship. Most studies have shown a neutral, or even slight negative impact. In all cases it is imperative to conduct a thorough analysis of the potential risks and benefits is required.

For a lot of women with ADHD, the decision to stop medication is difficult if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. A loss of medication may also affect the ability to drive safely and complete work-related tasks, which are vital aspects of everyday life for those with ADHD.

She recommends that women who are unsure about whether to keep or stop medication in light of their pregnancy consider informing family members, friends and colleagues on the condition, its effects on daily life, and the benefits of keeping the current treatment regimen. It can also make the woman feel more comfortable when she is struggling with her decision. Certain medications can pass through the placenta. If a woman decides to not take her ADHD medication while breastfeeding, it's important to be aware that the medication may be transferred to her infant.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns over the impact that these drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Utilizing two huge data sets, researchers were able to examine more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher rates of certain heart defects, such as ventriculoseptal defect.

The researchers of the study could not discover any link between early Medication for adhd and odd usage and other congenital anomalies, such as facial deformities or club feet. The results are in the same vein as previous studies that showed the existence of a slight, but significant increase in cardiac malformations for women who began taking ADHD medication before pregnancy. This risk increased during the latter part of pregnancy, as many women begin to discontinue their intuniv adhd medication medication.

Women who took ADHD medications in the first trimester of their pregnancies were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby that required breathing assistance during birth. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who didn't have other medical issues that could have contributed to these findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. They suggest that although discussing risks and benefits is important, the decision to stop or maintain treatment must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also advise that, while stopping the medication is an option, it isn't an option to consider due to the high rate of depression and other mental health problems in women who are pregnant or recently post-partum. Further, the research suggests that women who decide to stop taking their medication are more likely to experience difficulties adapting to life without them after the baby's arrival.

Nursing

The responsibilities of being a new mom can be overwhelming. Women with ADHD who have to deal with their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and getting used to new routines at home can experience severe challenges. Therefore, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs are absorbed through breast milk in small amounts, so the risk to breastfeeding infant is minimal. The rate of exposure to medication will vary based on the dosage and frequency of administration as well as the time of day. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk. The impact of this on a newborn infant is not well known.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. This is a difficult decision for the patient, who must balance the benefit of continuing her medication against the possible risks to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal time.

A increasing number of studies have proven that women can continue their ADHD medication during pregnancy and breastfeeding. In the end, many patients opt to do this and, after consulting with their doctor, they have found that the benefits of keeping their current medication exceed any risk.

It is essential for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be educated about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration and, if necessary modifications to the medication regime.